If the growth response to the experimental maneuver including exposure to mitogens, such as angiotensin II, EGF, insulin, and hydrocortisone in combination with TGF-␤, glucose, and increased concentrations of ammoKidney size increases in response to a variety of pathonium chloride [1, 2] . logic or abnormal situations, including the loss of renal When studying cell growth, these terms (hyperplasia, mass because of ablation or nephron dropout, diabetic hypertrophy, antiproliferation, and apoptosis) should be nephropathy, chronic metabolic acidosis, chronic potasused very specifically. An increase in kidney size does sium deficiency, a chronic increase in protein intake, not necessarily correlate with a hypertrophic growth reand pregnancy [1, 2] . In all of these conditions except sponse. It is possible for kidney size to increase in repregnancy, the increase in kidney size is associated with sponse to hyperplasia, an increase in water content of an increase in the size of the renal epithelial cells of the the kidney, such as occurs in pregnancy, cells infiltrating into the kidney, or to a true increase in cell size. tubule. Various nephron segments hypertrophy in these
In assaying cell growth, there are indices that are capaconditions; however, in all of these cases, there is an ble of differentiating between the various growth patincrease in proximal tubule epithelial cell size.
terns. If following a growth signal hyperplasia is the There are specific terms used to describe cell growth.
resulting growth response, then this growth response When a cell population is studied, if the experimental will be marked by increases in both DNA and protein maneuver leads to an increase in cell number, the growth synthesis and an increase in both the protein and DNA process is hyperplasia. This is the typical growth response contents of the sample so that there will be no change following exposure to mitogens, such as the growth facor perhaps even a small decrease in the ratio of protors platelet-derived growth factor and epidermal growth tein:DNA. Accompanying this lack of effect on the profactor (EGF).
tein:DNA ratio will be no effect on cell size. One qualifyIf growth is arrested by the experimental maneuver, ing statement should be made here. If the majority of then the growth process is one of antiproliferation. The the cells in the population being studied have recently term antiproliferation is reserved for the specific situaexited mitosis, then it is possible that both cell size and tion in which further growth is prevented. Ultimately, the protein:DNA ratio will be slightly smaller than the this will result in a decrease in cell number compared control population. This is because cells that have just with a control population of cells. Antiproliferation does exited mitosis need to accumulate a full complement of not refer to a decrease in cell number caused by cell cytoplasm before they achieve a mature cell size. death. That is the process of apoptosis. The prototype When the growth signal is one that leads to a hypertrophic growth response, then the growth pattern will be associated with an increase in protein content with or without a decrease in DNA content. Regardless of the effect on DNA, there will always be an increase in the 
CELL CYCLE-DEPENDENT MECHANISM OF HYPERTROPHY
The initial studies that we performed used cultured cells, both primary cultures of rabbit proximal tubule prevent the EGF-induced growth process, studies were cells and a continuous cell line, NRK-52E cells, a normal done to demonstrate that early mitogen-induced rerenal epithelial cell line. In all protocols tested, the responses occurred in both the EGF-and EGF ϩ TGFsults were the same between the two types of cells.
␤1-treated cells [6] . Three studies were performed. The Previous laboratories had demonstrated that renal tufirst examined c-fos mRNA abundance in control, EGF-, bule epithelial cells hypertrophy following exposure to TGF-␤1-, and EGF ϩ TGF-␤1-treated cells. TGF-␤1 the combination of a growth factor and an antiproliferaalone had no effect on c-fos mRNA abundance, whereas tive cytokine, such as TGF-␤1 [3] [4] [5] . Our first studies both the EGF-and EGF ϩ TGF-␤1-treated cells demonwere done to confirm that both primary cultures of rabbit strated a transient increase in c-fos mRNA abundance, proximal tubule cells and the NRK-52E cell line also which peaked at 30 minutes. This rapid, transient inhypertrophied under these conditions. A time course of crease in c-fos abundance is typical of cells crossing the exposure to EGF and/or TGF-␤1 was done in which it mitosis/G 1 or G 0 /G 1 interface. Thus, the immediate mitowas demonstrated that EGF leads to a hyperplastic gen-induced response was not modified by TGF-␤1 and, growth response: TGF-␤1 has an antiproliferative effect therefore, is not responsible for the conversion from a on cell growth, and the combination of the two leads to hyperplastic to hypertrophic growth response. a hypertrophic growth response [1, 2, 6, 7] . Thus, we
The second study examined the effect of EGF and reconfirmed that the combination of a mitogen plus an TGF-␤1 on protein synthesis, another event that typiantiproliferative cytokine leads to the development of cally occurs shortly after cells enter the G 1 phase. hypertrophy in renal tubule epithelial cells. In addition, 3 H-phenylalanine incorporation was used as the marker these studies provided a situation in which we could for protein synthesis. As with the c-fos studies, TGF-␤1 simultaneously compare a hyperplastic to a hypertrophic alone had no effect on protein synthesis, whereas both growth mechanism.
the EGF-and EGF ϩ TGF-␤1-treated cells demonCompared with control cells, the hyperplastic growth strated a robust increase in protein synthesis. response was associated with an increase in both protein
The third study looked at the regulation of cyclin E and DNA synthesis and content, no change in the proprotein abundance in both growth responses. Changes tein:DNA ratio, and no change in cell size. By compariin cyclin E protein abundance represent events that are son, the hypertrophic growth response was associated occurring in the mid-late G 1 period, and thus occur later with an increase in protein content, a decrease in DNA than either the effects on c-fos mRNA abundance or the synthesis, and an increase in both the protein:DNA ratio initiation of protein synthesis. Once again, the observaand the cell size. Thus, the hyperplasic growth response tion was the same: no effect of TGF-␤1 alone on cyclin (exposure to EGF alone) differs from the hypertrophic E protein abundance, but an increase in both EGF-and growth response (exposure to EGF ϩ TGF-␤1) by inhib-EGF ϩ TGF-␤1-treated cells. Thus, the three studies demonstrated that although the conversion of a hyperiting the EGF-induced increase in DNA synthesis, without effecting the EGF-induced increase in protein synplastic to hypertrophic growth response blocks movement into the S phase, it does not prevent the early thesis. Cell cycle analysis, using propidium iodide, was performed to confirm the DNA synthesis experiments.
events associated with mitogenic stimulation. Thus, the conversion must occur in the late G 1 phase. A requireIt was found that cells undergoing a hyperplastic growth response have more than one copy of DNA, whereas the ment for the cells to have progressed up to the late G 1 period is suggested by the studies in which cells were hypertrophied cells have a single copy of DNA. Taken together, these studies suggest that the development of exposed to TGF-␤1 alone. In this situation, the cells do not hypertrophy. hypertrophy is associated with the modification of an EGF-induced growth process.
Having demonstrated that the hypertrophying cells did enter and need to enter G 1 , we next looked at events To confirm that TGF-␤1 modified but did not entirely that occur at the G 1 /S interface [6, 8] . pRB, the retinober of cdk2/cyclin E complexes, (c) failure to activate the kinase, or (d) association of a cyclin kinase inhibitor blastoma protein, plays a key role in progression across the G 1 /S interface. As a cell enters G 1 , pRB is unphos-(CKI) with cdk2/cyclin E complexes that do form. We tested all of these possibilities and found the following phorylated. Early in G 1 , cyclin D kinase phosphorylates some of the sites on pRB, rendering the protein "active" [8] : TGF-␤1 had no effect on EGF-induced increases in either cdk2 or cyclin E protein abundances. Thus, a in the sense that it can now bind the transcription factor E2F and prevent transcription of genes required for deficiency in subunit abundance is not responsible for the decrease in kinase activity. Likewise, TGF-␤1 had no DNA synthesis in S phase. Late in G 1 , cyclin E kinase further phosphorylates pRB. In this hyperphosphoryeffect on the abundance of Cdc25A, the duel-specificity phosphatase that is responsible for removing the N-terlated state, the protein is "inactive" in that it can no longer bind E2F, and thus, transcription of S-phaseminal Tyr and Thr phosphate residues on cdk2. The removal of these phosphate molecules is necessary to required genes proceeds. It is the activation of cyclin E kinase, followed by the accumulation of S-phaseactivate the kinase [9] [10] [11] . Because in many cell systems, Cdc25A activity is regulated by regulating its protein required genes that marks the transition across the restriction point in late G 1 and entrance into S phase.
abundance, this observation suggests that preventing N-terminal Tyr and Thr dephosphorylation is not reIn affinity-purified lysates, EGF alone lead to a large increase in the abundance of the hyperphosphorylated sponsible for the reduction in kinase activity [12] [13] [14] .
Transforming growth factor-␤1 did, however, signifiform of pRB, consistent with a hyperplastic growth response. In the EGF ϩ TGF-␤1-treated cells, the abuncantly decrease the number of cdk2/cyclin E complexes that formed. This was determined by assaying the abundance of hyperphosphorylated pRB was the same as in control cells. Thus, TGF-␤1 blocked the entire EGFdance of cdk2 that coprecipitated with cyclin E. A reduction in complex abundance could clearly provide a mechassociated hyperphosphorylation of pRB, and all of the pRB protein remained in the hypophosphorylated, acanism by which kinase activity could be reduced. In addition, in complexes that did form in EGF ϩ TGFtive form. To determine whether it is necessary for pRB to be active, studies were done using the HPV 16 onco-␤1-treated cells, there was an increase in the abundance of the CKI p57 Kip2 associated with the complexes, comprotein E7, which binds the hypophosphorylated form of pRB, rendering it "inactive." In the presence of the pared with control cells. Increased association of an inhibitor provides another mechanism to explain the re-HPV16 E7 protein, TGF-␤1 was not able to convert the EGF-induced hyperplasia to hypertrophy. In fact, in duction in kinase activity. Taken together, these studies demonstrate that EGF ϩ these EGF ϩ TGF-␤1-treated cells, the growth response was hyperplasia. Complexing another cell cycle regula-TGF-␤1-mediated hypertrophy is due to the combination of two events. First, EGF causes the cells to enter tory protein, p53, with another HPV 16 oncoprotein, E6, had no effect on the ability of TGF-␤1 to convert EGFthe cell cycle, initiate protein synthesis, activate cyclin D, and phosphorylate pRB sufficiently to activate the induced hyperplasia to hypertrophy. Thus, it is clear that the development of hypertrophy requires mitogenprotein. TGF-␤1 does not modify any of these EGFmediated events. Second, TGF-␤1 blocks EGF-induced induced entrance into G 1 , followed by an arrest of cell cycle progression at the G 1 /S interface and that pRB activation of cyclin E kinase, preventing hyperphosphorylation and thus inactivation of pRB. The consequence must be active for hypertrophic growth to occur.
Taken together, the studies demonstrated that it is a of this event is that cell cycle progression is arrested, and the cells continue to reside in late G 1 . It is clear that late G 1 event that is being modified by TGF-␤1 and is necessary to convert hyperplasia to hypertrophy. As both of these events must occur. If the cells do not enter the G 1 phase, as would occur in the absence of mitogenic regulation of pRB activity is governed by the G 1 kinase, we next measured cyclin D and E kinase activities [8] .
stimulation, or if cell cycle progression is not arrested at the G 1 /S interface, as would occur when pRB is inactiAs expected, if a late G 1 event is what is responsible for the development of hypertrophy, TGF-␤1 had no effect vated, the resulting growth pattern would be antiproliferation or hyperplasia, respectively, but not hypertrophy. on the EGF-induced increase in cyclin D kinase activity, assayed in cyclin dependent kinase 4 (cdk4), cyclin D1, Based on these observations, we propose a model for the development of hypertrophy that we refer to as cell cyclin D3, and cdk6 immunoprecipitates. However, TGF-␤ reduced the EGF-induced increase in cyclin E cycle dependent (Fig. 1) . Following either a hyperplastic or hypertrophic growth stimulus that causes the cells to kinase activity by greater than 75% [8] . These studies further confirm that the development of hypertrophy enter the cell cycle, cyclin D kinase is activated and protein synthesis increases. Because both hyperplasia occurred by modifying an EGF-induced late G 1 event.
Inhibition of cyclin E kinase activity could be caused and this form of hypertrophy result in an increase in the physical size of the cell, either transiently in the case of by either (a) a decrease in the availability of the kinase subunits (cdk2 and cyclin E), (b) a decrease in the numhyperplasia or permanently in the case of hypertrophy, we propose that cyclin D kinase is initiating and mediatmade on isolated proximal tubules; BrdU incorporation ing the increase in physical growth.
into cortical proximal tubules is used as a marker for It is then the events of the late G 1 phase that differenti-DNA synthesis and cyclin D and E kinase activities are ate hyperplasia from cell cycle-dependent hypertrophy. measured on either cortical homogenate or isolated If cyclin E kinase is activated sufficiently to phosphoryproximal tubule homogenate. For the kinase activities, late pRB fully, the protein is inactivated, S-phase rethe results are the same for the cortical and isolated quired genes are transcribed, the cell progresses into S proximal tubule homogenates, demonstrating that changes phase, and hyperplasia is the resulting growth pattern.
in cortical kinase activity reflect changes in proximal However, if cyclin E kinase is not activated sufficiently tubule kinase activity. Nevertheless, most kinase studies to phosphorylate pRB, then the protein remains in its are done on isolated proximal tubule preparations. active state, the S-phase required genes are not tranCompensatory renal growth following the loss of renal scribed, cell cycle progression is arrested, and under the mass is induced by uninephrectomy. This form of growth continued activity of cyclin D kinase, the cells continue is associated with a progressive increase in kidney weight to grow and remain enlarged and hypertrophy is the and the protein:DNA ratio of isolated proximal tubules. resulting growth pattern.
The compensatory growth period is associated with the activation of cortical cyclin D kinase activity four-days postnephrectomy, but a return toward baseline levels at MECHANISM OF RENAL GROWTH FOLLOWING THE LOSS OF RENAL MASS days 7 and 14. In contrast, cortical cyclin E kinase activity is increased 2 days postnephrectomy, remains elevated The in vitro EGF ϩ TGF-␤1 hypertrophy model proat 4 and 7 days, and returns to baseline levels at 14 days. vides a mechanism for examining the development of Despite activation of cyclin E, there is no increase in hypertrophy in vivo. Based on the patterns of G 1 kinase BrdU incorporation of proximal tubules, thus demonactivity, DNA synthesis, and the protein:DNA content strating that insufficient cyclin E kinase activity was presratio, we are able to differentiate hyperplasia from cell ent to inactivate pRB and permit movement into S phase. cycle-dependent hypertrophy and to determine under A growth pattern in which there is an increase in the what conditions renal epithelial cells hypertrophy. Folprotein:DNA ratio and no increase in BrdU incorporalowing uninephrectomy and in other in vivo growth models, the protein and DNA content measurements are tion is characteristic of a purely hypertrophic growth (abstract; Liu and Preisig, J Am Soc Nephrol 8:424A, which is evident at day 2. At this time point, both cyclin 1997).
D and E kinase activities are increased. Cyclin D kinase To determine if the small increase in cyclin E kinase activity remains elevated at days 5 and 10, whereas cyclin activity is necessary for the development of hypertrophy, E kinase activity is inhibited compared with control rats rats were given Roscovitine, a cdk2/cyclin E kinase inhibat both days 5 and 10. BrdU incorporation is only initor (abstract; Liu and Preisig, J Am Soc Nephrol 9:444A, creased at day 2, at which time both cyclin D and E 1998). In the presence of Roscovitine in sham rats, baseactivities are increased. The profile of BrdU incorporaline cyclin E kinase is inhibited. In nephrectomized rats, tion matches the activation and then inhibition of cyclin Roscovitine significantly decreases the nephrectomy-E kinase activity. Tubular hypertrophy, assayed as an induced increase in cyclin E activity. Despite inhibition increase in the protein:DNA ratio of isolated proximal of cyclin E kinase, Roscovitine has no effect on the tubules, is clearly evident at day 10. At this time point, development of hypertrophy following uninephrectomy.
cyclin D activity has been increased, whereas cyclin E In both sham and nephrectomized rats, Roscovitine inactivity has been inhibited for a number of days. Thus, creases cyclin D activity. In sham rats, the activation of diabetic-induced tubular epithelial growth initially incyclin D and the inhibition of cyclin E by Roscovitine volves proximal tubule hyperplasia, followed later by causes the development of hypertrophy, even without hypertrophy. As the hyperplasia is associated with actithe loss of renal mass, demonstrating that the pattern of vation of both cyclin D and E kinases and the hypertrokinase regulation plays a role in the development of phic growth period associated with only cyclin D kinase hypertrophy.
activation, this form of renal epithelial cell hypertrophy The role of NH 3 in compensatory renal hypertrophy also involves a cell cycle-dependent mechanism. was examined by feeding sham and uninephrectomized rats an alkaline diet and comparing them with rats receiv-SUMMARY ing the same diet to which NaCl was added. In sham rats, the alkaline diet decreases renal NH 3 excretion, In summary, in in vivo [compensatory renal growth, suggestive of a decrease in ammoniagenesis. However, diabetic nephropathy, and the reparative phase following the alkaline diet has no effect on the protein:DNA ratio an episode of transient ischemia (data not discussed)] of isolated proximal tubules in sham or nephrectomized as well as in vitro (cultured renal epithelial cell) renal rats, suggesting that ambient renal [NH 3 ] does not play epithelial cell growth models, cyclin D kinase activity is a role in compensatory renal growth following uniassociated with the physical growth that occurs in hypernephrectomy. As a control, the effect of an alkaline diet plasia and some forms of hypertrophy. In these condion chronic hypokalemic-induced renal growth was examtions in which cyclin D kinase is activated, the level of ined. Compared with control rats, chronic hypokalemia cyclin E kinase activity determines entrance into S phase increases renal ammonia excretion and leads to an inand thus defines the growth pattern as hypertrophy or crease in kidney size (assayed as the kidney:body weight hyperplasia. The distinct pattern of kinase activity perratio). The addition of alkali to the K-deficient diet demits classification of renal hypertrophy in clinical condicreases renal ammonia excretion and returns the kidtions as being mediated by a cell cycle-dependent or ney:body weight ratio back toward control values. Thus, -independent process. The latter is not discussed in this in chronic hypokalemic, but not compensatory renal article (abstract; Liu and Preisig, J Am Soc Nephrol growth, ambient renal NH 3 appears to play a role in the 9:444A, 1998; abstract; Huang and Preisig, J Am Soc renal growth.
Nephrol 9:440A, 1998) [1, 2, 6, 7, 15]. Taken together, these studies characterize compensatory renal hypertrophy as a cell cycle-dependent process.
